The Glucagon-like peptide (GLP-1) receptor agonist semaglutide could help people living with HIV (PLWH) lose weight gained after starting antiretroviral treatment (ART)but it may also exacerbate muscle loss or lipoatrophy, according to research presented at IDWeek 2023 in Boston, Massachusetts
This significant reduction was achieved through a combination of a controlled diet, strict gym workouts, and, as is known now, wearing the sauna suit for excessive heat and sweat
From potential improvements in inflammatory skin conditions to common side effectsand even nutrition products that support the skin-GLP-1 connectionheres what emerging research is revealing about how these medications might impact your skin, from the inside out
In the in vitro study, the concentration of lutein needed to inhibit phase I enzymes 50% was less than 12 mg/mL for CYP1A1, CYP1A2, CYP2B1/2, aniline hydroxylase, and aminopyrine- N -demethylase
"Serena Williams can be doing so much to champion women's sports or the importance of body positivity but instead is pushing a weight loss drug in her retirement," a fan wrote on X
If GLP-1 agents reduce incidence (as observational studies suggest), that may translate into clinically meaningful delay